The obtained results clearly demonstrate that the nutraceutical market contains substandard products. Efforts are required in order to strengthen regulations for granting and renewal of marketing authorisation to nutraceuticals. It also suggested that modern formulation and packaging technologies commonly employed in the pharmaceutical industry should be implemented in the nutraceutical industry. Our findings confirm that the use of validated stability-indicating testing protocols is indispensable during both pre-formulation and batch release operations in the nutraceutical industry.